Recombinant single domain antibody to insulin-like growth factor binding protein 7. 4.6-IGFBP7 is a single domain antibody that can be potentially used in the treatment of neoplastic diseases.
Figure 1 ELISA on clone 4.6-IGFBP7
standard ELISA in which IGFBP7 was coated on microtitre plates and binding of sdAb clone 4.6-IGFBP7 was assessed.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.